Seemingly harmless, symptomless virus may actually cause Parkinson's disease: study
Now, scientists have discovered that a virus that has flown under the radar for years might be a potential contributor to the neurodegenerative disorder.
'We wanted to investigate potential environmental factors – such as viruses – that might contribute to Parkinson's disease,' Igor Koralnik, the lead author of the study and chief of neuroinfectious diseases and global neurology at Northwestern Medicine, said in a press release.
Advertisement
3 Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a potential contributor to the neurodegenerative disorder.
Laura Brown
'Using a tool called 'ViroFind', we analyzed post-mortem brain samples from individuals with Parkinson's and from those who died of other causes. We searched for all known human-infecting viruses to identify any differences between the two groups.'
What they found was that the Human Pegivirus (HPgV) — a blood-borne, symptomless virus from the same family as hepatitis C — was present in the brains and spinal fluid of 50% of people with Parkinson's but not in those without it.
The findings — published Tuesday in the journal JCI Insight — could be a major breakthrough in unlocking some of the factors that lead to this tricky disease and provide new insight into a virus that was previously considered benign.
Advertisement
'HPgV is a common, symptomless infection previously not known to frequently infect the brain,' Dr. Koralnik said.
'We were surprised to find it in the brains of Parkinson's patients at such high frequency and not in the controls. Even more unexpected was how the immune system responded differently, depending on a person's genetics.'
'This suggests it could be an environmental factor that interacts with the body in ways we didn't realize before.
Advertisement
'For a virus that was thought to be harmless, these findings suggest it may have important effects, in the context of Parkinson's disease. It may influence how Parkinson's develops, especially in people with certain genetic backgrounds.'
3 What they found was that the Human Pegivirus (HPgV) — a blood-borne, symptomless virus from the same family as hepatitis C — was present in the brains and spinal fluid of 50% of people with Parkinson's but not in those without it.
C Davids/peopleimages.com – stock.adobe.com
Blood samples from more than 1,000 people enrolled in the Parkinson's Progression Markers Initiative, a project launched by The Michael J. Fox Foundation, showed that people with HPgV had unique immune system 'signals' — patterns that appeared both in the bloodstream and the brain.
Advertisement
'With the blood samples, we observed similar immune-related changes, mirroring those found in the brain,' Dr. Koralnik said.
'People who had the virus showed different signals from the immune system than those who didn't, and this pattern was the same, no matter the genetics. But as we followed each person over time, we saw a more complicated picture.'
In people with a Parkinson's-linked mutation in the LRRK2 gene, the immune system reacted to the virus differently than in those without the mutation — suggesting the virus may interact with certain genes to help set the disease in motion.
3 Blood samples from more than 1,000 people enrolled in the Parkinson's Progression Markers Initiative, a project launched by The Michael J. Fox Foundation.
Getty Images
'We plan to look more closely at how genes like LRRK2 affect the body's response to other viral infections to figure out if this is a special effect of HPgV or a broader response to viruses,' added Dr. Koralnik.
Now, the team wants to go bigger, examining more brains to determine how often HPgV sneaks past the blood-brain barrier.
'One big question we still need to answer is how often the virus gets into the brains of people with or without Parkinson's,' said Dr. Koralnik.
'We also aim to understand how viruses and genes interact; insights that could reveal how Parkinson's begins and could help guide future therapies.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
TELUS Health for Good™ and Victoria Cool Aid Society launch series of hepatitis C testing events in Victoria
In recognition of World Hepatitis Day, TELUS and Victoria Cool Aid Society support life-saving screening for high-risk populations VICTORIA, BC, July 24, 2025 /CNW/ - Today, Victoria Cool Aid Society and TELUS Health for Good launched a series of hepatitis C testing events enabled through the two Cool Aid Mobile Health Clinics powered by TELUS Health. Today's event takes place at Victoria's largest shelter, Rock Bay Landing, with Cool Aid staff on site delivering hepatitis C rapid testing and TELUS volunteers providing nutritional support, helping to facilitate access to essential health services. With additional events planned throughout the remainder of the year, this collaboration will enable Cool Aid to reach their goal of completing 700 hepatitis C tests in 2025. "Hepatitis C often has no symptoms, so you could have it without knowing," said Tamara Barnett, Hepatitis C Program Coordinator, Cool Aid Community Health Centre. "Getting tested helps you start treatment early, avoid liver damage, and prevents passing the virus on to others. Our peer-led testing program has screened over 1,900 people to date, leading to over 50 successful treatments. This support from TELUS will allow us to test more people than ever this year." "At TELUS, we are driven by our collective desire to leverage technology and human compassion to enable better health outcomes for vulnerable populations," said Nimmi Kanji, Executive Director TELUS Friendly Future Foundation and TELUS Social Purpose Programs. "Through our longstanding partnership with Victoria Cool Aid Society, we are enabling access to life-saving hepatitis C testing directly to those facing significant barriers to accessing traditional healthcare. By combining our mobile health technology with community-based care, we are ensuring that early detection and treatment is accessible to those who need it most, helping create a healthier, more inclusive future for all." Hepatitis C is an infection of the liver that, if left untreated, can lead to serious health problems including liver damage, cirrhosis, and liver cancer. With no vaccine available and more than 50 million people affected worldwide, including approximately 200,000 Canadians, early detection and treatment can be life-saving. According to studies, the prevalence of hepatitis C can be 10 times higher among people experiencing housing instability compared to the overall population. Fortunately, the testing process is quick, easy, and accurate, with treatment curing 95 per cent of people within 8 to 12 weeks. Building on decades of primary healthcare and social support services, the two Cool Aid Mobile Health Clinics powered by TELUS Health have supported more than 40,000 patient visits across Greater Victoria since their respective launches in 2021 and 2023. In addition to point-of-care testing, the mobile clinics also provide wound care, STI treatment, harm reduction, outreach, and mental health care services to Victorians in need. Additional hepatitis C testing events will take place at community locations across Victoria throughout the remainder of 2025, with dates and locations to be announced shortly. To learn more about TELUS Health for Good, visit About TELUS Health for Good Since 2014, TELUS Health for Good has been connecting underserved individuals to the medical and mental health care they need using the power of technology. Backed by a commitment of $16 million through 2027, TELUS Mobile Health Clinics have now supported over 300,000 patient visits across 27 Canadian communities since inception. Equipped with TELUS electronic medical records technology, and fuelled by compassion, our Mobile Health Clinics provide essential primary medical care to individuals living on the streets. The program also supports caregivers experiencing marginalization with access to free TELUS Health MyCare Counselling sessions and supports low-income older adults to live more independently and enjoy peace of mind with low-cost TELUS Health Medical Alert services. To learn more about TELUS Health for Good, visit About TELUS TELUS (TSX: T, NYSE: TU) is a world-leading communications technology company operating in more than 45 countries and generating over $20 billion in annual revenue with more than 20 million customer connections through our advanced suite of broadband services for consumers, businesses and the public sector. We are committed to leveraging our technology to enable remarkable human outcomes. TELUS is passionate about putting our customers and communities first, leading the way globally in client service excellence and social capitalism. Our TELUS Health business is enhancing more than 150 million lives across 200 countries and territories through innovative preventive medicine and well-being technologies. Our TELUS Agriculture & Consumer Goods business utilizes digital technologies and data insights to optimize the connection between producers and consumers. Guided by our enduring 'give where we live' philosophy, TELUS, our team members and retirees have contributed $1.8 billion in cash, in-kind contributions, time and programs including 2.4 million days of service since 2000, earning us the distinction of the world's most giving company. We're always building Canada. For more information, visit or follow @TELUSNews on X and @Darren_Entwistle on Instagram. About the Victoria Cool Aid Society The Victoria Cool Aid Society believes that everyone deserves home, health and community. We create opportunities for people who are experiencing homelessness or living in poverty and we make a difference through housing, health and dental care, community, and emergency shelters. Founded in 1968, Cool Aid helps more than 12,000 people in the Capital region every year, at 20 locations in Victoria, Saanich and Langford, including more than 7,000 Community Health Centre patients. For more information about Cool Aid, visit For media inquiries, please contact: Saara RahikkaTELUS Media Relations SOURCE TELUS Communications Inc. View original content to download multimedia: Sign in to access your portfolio
a day ago
What to know about Parkinson's disease following Ozzy Osbourne's death
Ozzy Osbourne, lead singer of the legendary heavy metal rock band Black Sabbath, died this week at age 76. Although Osbourne's cause of death hasn't yet been publicly released, he revealed in an exclusive interview with " Good Morning America" in 2020 that he had been diagnosed with Parkinson's disease in February of the previous year. "There's so many different types of Parkinson's. It's not a death sentence by any stretch of the imagination but it does affect certain nerves in your body," Osbourne's wife, Sharon, said during the interview. "And it's like you have a good day, a good day, and then a really bad day." Here's what you need to know about Parkinson's, including what are the symptoms, how it's diagnosed and what treatments are available. What is Parkinson's disease? Parkinson's is a neurodegenerative disorder characterized by the weakening of nerve cells, which become damaged and die, according to the National Institute of Neurological Disorders and Stroke (NINDS). The most significant loss of neurons occurs in an area near the base of the brain called the substantia nigra, NINDS said. The neurons in the substantia nigra produce dopamine, which is a neurotransmitter that plays a vital role in controlling movement. "As we grow older, all of us lose dopamine but the people who develop Parkinson's disease lose it faster," Dr. Osama Abu-Hadid, a neurologist specializing in movement disorders at New Jersey's Hackensack Meridian Neuroscience Institute at Hackensack University Medical Center, told ABC News. Parkinson's affects more than 1.1 million people in the U.S., according to the Parkinson's Foundation. That figure is expected to reach 1.2 million by 2030. "Generally, neurodegenerative diseases such as Alzheimer's and Parkinson's disease have been on the increase because people are living longer," Abu-Hadid said. There currently are no specific tests to diagnose Parkinson's disease. The diagnosis is clinical based on a physician's review of a patient's medical history and by performing a physical examination. What are the symptoms of Parkinson's disease? Progression of Parkinson's disease symptoms typically occurs slowly over several years and can vary from person to person, according to the Parkinson's Foundation. Typically, symptoms begin on one side of the body. While Parkinson's will eventually affect both sides of the body, one side will generally exhibit more severe symptoms than the other, according to NINDS. Symptoms of Parkinson's can include tremors, muscle stiffness, slowing of spontaneous movement, and problems with gait and balance. Patients may also experience difficulty chewing and swallowing or changes in speech. Some patients can also develop non-motor symptoms, including constipation, hallucinations, depression, loss of smell and sleep problems, Abu-Hadid said. What Parkinson's disease treatments are available? Currently, there is no cure for Parkinson's, but physical therapy can help slow progression of the disease and a healthy diet can promote overall well-being, according to Abu-Hadid. However, there are medications that may improve some Parkinson's symptoms. These include drugs that increase the level of dopamine in the brain, drugs that interact with other neurotransmitters to help ease some symptoms, and medications that can help control the non-motor symptoms, according to NINDS. If medications aren't working, "procedural options include deep brain stimulation, which is an electrode, or electrodes, that are placed in the brain by a neurosurgeon, and then a physician like myself programs the electrodes to give electricity in a certain way," Abu-Hadid said. The electrodes can stimulate the brain and help block signals that cause the motor symptoms of Parkinson's, according to NINDS.
Chicago Tribune
a day ago
- Chicago Tribune
What to know about Parkinson's disease after Ozzy Osbourne's death
Heavy metal rocker Ozzy Osbourne died this week at 76, just weeks after his farewell show and about five years after announcing he had Parkinson's disease. Here's what to know about the disease: Parkinson's is a neurologic disease that robs people of control over their movements. It typically starts with tremors and is characterized by slow movement, a shuffling gait, stiff limbs, balance problems and slurred speech. About 1 million Americans are living with Parkinson's, and 10 million people worldwide, the Parkinson's Foundation estimates. It usually appears after age 60, although sometimes it can develop before age 50. The exact cause isn't known, but Parkinson's develops when cells that produce one of the brain's chemical messengers, called dopamine, begin to deteriorate and die. Dopamine transports signals to parts of the brain that control movement. Parkinson's symptoms appear after enough dopamine-producing cells die that there's too little of this neurotransmitter in the brain. According to the foundation, most experts believe genetic and environmental factors are behind the disease. Dozens of gene mutations linked to Parkinson's have been discovered and genetics account for 10% to 15% of all cases. Other factors suspected of increasing the risk include head injuries, exposure to pesticides and herbicides and where you live. Ozzy Osbourne, lead singer of Black Sabbath and godfather of heavy metal, dies at 76There is no cure but there are treatments, including medications that affect dopamine levels and a surgically implanted tremor-blocking device. Patients also can benefit from physical and occupational therapy. Symptoms worsen over time, usually slowly. The severity of symptoms and how quickly they progress varies widely between patients. In advanced cases, people may be unable to walk or care for themselves. They also can suffer from depression as well as memory and thinking problems. While Parkinson's itself isn't considered fatal, people can die from complications of the disease, including lung problems as muscle weakness impedes the ability to cough and to swallow.
